Gastric Ulcers Market Trends and Insights: Global Forecast to 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the gastric ulcers market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Gastric Ulcers Market size between 2026 and 2035?

The gastric ulcers market has shown strong expansion in recent years. It is projected to increase from $4.53 billion in 2025 to $4.78 billion in 2026, at a compound annual growth rate (CAGR) of 5.5%. Historically, this growth can be attributed to the prevalence of h pylori infection, widespread use of antacids, availability of antibiotics, hospital-based GI treatments, and adoption of endoscopic diagnosis.

The market for gastric ulcers is anticipated to experience consistent expansion over the upcoming years. This market is projected to reach $5.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. This expansion during the projection period stems from factors such as the creation of advanced acid-suppression medications, the need for ongoing ulcer treatment, a rise in outpatient services, enhancements in diagnostic technologies, and an increase in lifestyle-related health conditions. Key developments expected in the forecast timeframe involve a greater reliance on proton pump inhibitors, an increasing emphasis on eradicating helicobacter pylori, the proliferation of combination drug treatments, the broadening of non-invasive diagnostic techniques, and heightened public understanding of gastrointestinal disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Drivers Are Impacting Market Performance In The Gastric Ulcers Market?

The expanding elderly demographic is projected to drive the future expansion of the gastric ulcers market. This demographic typically encompasses individuals 65 years and older, who have distinct health concerns associated with aging. Growth in the geriatric population stems from progress in healthcare, resulting in extended life spans and a decrease in birth rates across numerous global regions. Gastric ulcers are frequently observed among the elderly because of elevated NSAID usage and reduced mucosal defense, which often escalates the risk of complications. For example, data from January 2024, provided by the Population Reference Bureau (PRB), a US-based private non-profit organization, indicates that the population of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. Furthermore, the proportion of this demographic within the total population is forecasted to climb from 17% to 23%. This demographic transition points to a notable aging pattern within the U.S. population. These projections underscore the growing necessity of catering to the requirements of older adults across diverse sectors. Consequently, the expanding geriatric population is fueling the advancement of the gastric ulcers market.

Which Segments Are Contributing To The Growth Of The Gastric Ulcers Market?

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Which Trends Are Influencing The Performance And Direction Of The Gastric Ulcers Market?

Leading companies in the gastric ulcer market are concentrating on developing innovative products, such as new formulations of drugs, to improve treatment efficacy and minimize side effects. New formulation drugs refer to medications created with novel combinations of active ingredients, delivery systems, or dosage forms to enhance their effectiveness, safety, and patient adherence. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched Rabeprazole + Levosulpiride SR Capsules to provide enhanced relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively treating gastrointestinal disorders like gastroesophageal reflux disease (GERD) and gastric ulcers. This formulation not only reduces gastric acid secretion but also enhances gastric motility, offering comprehensive relief from symptoms such as heartburn and indigestion.

Who Are The Prominent Global Companies Shaping The Gastric Ulcers Market Landscape?

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Which Region Currently Holds The Largest Share Of The Gastric Ulcers Market?

North America was the largest region in the gastric ulcers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastric Ulcers Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

Browse Through More Reports Similar to the Global Gastric Ulcers Market 2026, By The Business Research Company

Duodenal Ulcer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/duodenal-ulcer-treatment-global-market-report

Peptic Ulcer Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Pressure Ulcers Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/pressure-ulcers-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795